Apr 24, 2019 3:28 pm EDT CollPlant Announces Publication of Study in Science Translational Medicine Showing Composite Matrix Based on rhCollagen, Ceramics and Bone Morphogenic Protein Led to Bone Growth Superior to Standard of Care
Apr 23, 2019 7:00 am EDT CollPlant to Present at ThinkEquity Conference on May 2, 2019 in New York City
Apr 1, 2019 1:14 pm EDT CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update
Mar 18, 2019 8:00 am EDT CollPlant Renews Distribution Agreement for Its Soft Tissue Repair Product Vergenix™STR With Arthrex a World Leader in Orthopedics
Mar 11, 2019 7:00 am EDT Study Published in Wounds Journal Shows Remarkable Wound Closure Performance With CollPlant's VergenixFG in the Treatment of Chronic Wounds With a 94% Median Wound Area Reduction Within 4-weeks
Feb 19, 2019 6:00 am EST CollPlant Announces Approval of Its rhCollagen Manufacturing Facility by European Union Notified Body
Dec 10, 2018 9:04 am EST Clinical Trial Published in the Journal of Shoulder and Elbow Surgery Concludes That CollPlant's Vergenix™ STR Effectively Demonstrates Significant Clinical Improvements in Tennis Elbow
Nov 29, 2018 8:07 am EST CollPlant Reports Third Quarter 2018 Financial Results and Provides Business Update
Nov 12, 2018 6:00 am EST CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
